SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000947871-23-000219
Filing Date
2023-02-23
Accepted
2023-02-23 13:58:53
Documents
1
Period of Report
2023-02-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 8199
  Complete submission text file 0000947871-23-000219.txt   10844
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Issuer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022-4629
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022-4629 (212) 739-6400
OrbiMed Capital GP VIII LLC (Reporting) CIK: 0001845804 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39743 | Film No.: 23658733

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9001 212-739-6400
OrbiMed Advisors IV Ltd (Reporting) CIK: 0001966835 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39743 | Film No.: 23658731

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK, NY 10022
Business Address 190 ELGIN AVENUE GEORGE TOWN GRAND CAYMAN E9 KY1-9001 212-739-6400
OrbiMed Asia GP IV, L.P. (Reporting) CIK: 0001966836 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39743 | Film No.: 23658732